| Ticker | Company | Price / Return |
| VIR | Vir Biotechnology, Inc | 8.46 (10.81%) |
| AQB | AquaBounty Technologies, Inc | 1.94 (4.86%) |
| PASG | Passage Bio, Inc | 1.30 (6.56%) |
| AIM | AIM ImmunoTech Inc | 0.41 (0.86%) |
| LABD | Direxion Daily S&P Biotech Bear 3X Shares | 10.06 (-8.79%) |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 19.55 (-5.00%) |
| BBH | VanEck Vectors Biotech ETF | 156.43 (1.07%) |
| BNTX | BioNTech SE | 88.78 (2.39%) |
| BDTX | Black Diamond Therapeutics, Inc | 5.58 (9.30%) |
| KROS | Keros Therapeutics, Inc | 56.42 (4.12%) |
| XXII | 22nd Century Group, Inc | 1.64 (-10.38%) |
| PLRX | Pliant Therapeutics, Inc | 11.84 (-0.38%) |
| GMAB | Genmab A/S | 27.72 (0.95%) |
| RNA | Avidity Biosciences, Inc | 24.17 (1.43%) |
| PCVX | Vaxcyte, Inc | 60.61 (0.92%) |
| OCGN | Ocugen, Inc | 1.31 (11.44%) |
| TLSA | Tiziana Life Sciences | 0.66 (-22.35%) |
| IPHA | Innate Pharma S.A | 2.27 (-5.42%) |
| OGEN | Oragenics, Inc | 1.03 (-2.36%) |
| NKTX | Nkarta, Inc | 6.68 (-1.98%) |
| PSTX | Poseida Therapeutics, Inc | 2.44 (18.78%) |
| RLAY | Relay Therapeutics, Inc | 6.54 (6.34%) |
| ITOS | iTeos Therapeutics, Inc | 10.76 (1.51%) |
| PSNL | Personalis, Inc | 1.47 (17.20%) |
| INBX | Inhibrx, Inc | 34.03 (-0.18%) |
| ATHA | Athira Pharma, Inc | 1.98 (2.86%) |
| SAVA | Cassava Sciences, Inc | 22.14 (1.89%) |
| CVM | CEL-SCI Corporation | 1.45 (-0.34%) |
| KYMR | Kymera Therapeutics, Inc | 33.60 (0.75%) |
| GLSI | Greenwich LifeSciences, Inc | 12.64 (2.47%) |
| PRLD | Prelude Therapeutics Incorporated | 3.82 (-5.45%) |
| TSHA | Taysha Gene Therapies, Inc | 2.43 (5.65%) |
| CCCC | C4 Therapeutics, Inc | 6.31 (1.12%) |
| IMNM | Immunome, Inc | 14.11 (-1.09%) |
| AUPH | Aurinia Pharmaceuticals Inc | 5.09 (4.52%) |
| FGEN | FibroGen, Inc | 1.14 (11.27%) |
| IGC | India Globalization Capital, Inc | 0.54 (25.58%) |
| GOVX | GeoVax Labs, Inc | 1.43 (-2.72%) |
| FHTX | Foghorn Therapeutics Inc | 5.50 (5.26%) |
| KZIA | Kazia Therapeutics Limited | 0.37 (1.70%) |
| SPRB | Spruce Biosciences, Inc | 0.71 (1.11%) |
| ATNF | 180 Life Sciences Corp | 2.14 (23.70%) |
| BIB | ProShares Ultra Nasdaq Biotechnology | 50.54 (3.27%) |
| LCTX | Lineage Cell Therapeutics, Inc | 1.09 (-1.35%) |
| IMVT | Immunovant, Inc | 27.46 (-1.05%) |
| JAN | JanOne Inc | 3.56 (-24.42%) |
| CRDF | Cardiff Oncology, Inc | 4.35 (9.02%) |
| GNFT | Genfit SA | 3.51 (2.93%) |
| PRTA | Prothena Corporation plc | 20.36 (-0.97%) |
| ADAG | Adagene Inc | 2.23 (-5.11%) |
| CDXC | ChromaDex Corporation | 3.52 (3.69%) |
| VIRI | Virios Therapeutics, LLC | 0.44 (-5.61%) |
| SANA | Sana Biotechnology, Inc | 9.01 (5.94%) |
| BCAB | BioAtla, Inc | 2.27 (0.67%) |
| NAUT | Nautilus Biotechnology Inc | 2.66 (12.71%) |
| RLYB | Rallybio Corporation | 1.94 (17.27%) |
| ENVB | Enveric Biosciences, Inc | 0.94 (2.49%) |
| HOWL | Werewolf Therapeutics Inc | 6.25 (0.64%) |
| FDMT | 4D Molecular Therapeutics, Inc | 23.96 (1.83%) |
| IKT | Inhibikase Therapeutics, Inc | 1.49 (-20.16%) |
| ATNM | Actinium Pharmaceuticals, Inc | 7.68 (17.07%) |
| TCRX | Tscan Therapeutics Inc | 7.78 (6.72%) |
| CTKB | Cytek BioSciences Inc | 6.00 (6.57%) |
| GHRS | GH Research PLC | 11.00 (4.76%) |
| ABSI | Absci Corp | 4.75 (6.51%) |
| TIL | Instil Bio, Inc. | 10.49 (0.96%) |
| ERAS | Erasca Inc | 2.03 (7.98%) |
| RPID | Rapid Micro Biosystems Inc | 0.94 (-0.98%) |
| CADL | Candel Therapeutics, Inc. | 7.05 (9.64%) |
| COGT | Cogent Biosciences, Inc. | 6.50 (8.15%) |
| ADTX | Aditxt, Inc. | 2.40 (-5.14%) |
| VYNE | VYNE Therapeutics Inc | 2.53 (2.43%) |
| KTTA | Pasithea Therapeutics | 6.87 (0.00%) |
| MGTX | MeiraGTx Holdings plc | 4.87 (3.40%) |
| AURA | Aura Biosciences | 7.40 (4.52%) |
| AVTE | Aerovate Therapeutics Inc | 19.95 (-7.53%) |
| LIXT | Lixte Biotechnology | 2.87 (-11.69%) |
| VRDN | Viridian Therapeutics, Inc. | 13.27 (4.49%) |
| SEEL | Seelos Therapeutics, Inc | 0.28 (-1.96%) |
| RANI | Rani Therapeutics | 6.38 (-2.74%) |
| GLUE | Monte Rosa Therapeutics Inc | 5.33 (-2.20%) |
| OMGA | Omega Therapeutics | 2.23 (-4.89%) |
| IPSC | Century Therapeutics Inc | 2.95 (-6.35%) |
| CRBU | Caribou Biosciences Inc | 3.63 (-3.46%) |
| ISPC | iSpecimen Inc | 0.29 (3.50%) |
| LYEL | Lyell Immunopharma Inc | 2.17 (-1.14%) |
| ANTX | AN2 Therapeutics | 2.41 (5.70%) |
| HLVX | Hillevax Inc | 13.16 (9.48%) |
| PEPG | PepGen Inc. | 12.24 (4.62%) |
| ACLX | Arcellx Inc. | 49.92 (-2.84%) |
| DYN | Dyne Therapeutics, Inc | 25.30 (6.79%) |
| JANX | Janux Therapeutics | 56.91 (20.83%) |
| XBI | SPDR S&P BIOTECH ETF | 84.55 (2.83%) |
| PALI | Palisade Bio Inc | 6.01 (-3.53%) |
| IRON | Disc Medicine Inc. | 27.90 (5.20%) |
| TSBX | Turnstone Biologics Corp. | 2.59 (-10.69%) |
| TKNO | Alpha Teknova Inc | 1.76 (2.33%) |
| AZTR | Azitra Inc | 0.22 (-0.14%) |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares ETF | 90.73 (8.38%) |
